Diagnosed last year, Taylor reports that vorasidenib provides her with increased stability and energy, helping her manage symptoms like dizziness and fatigue, and allowing her to spend meaningful time with her daughter.

A mother from Peterborough, Taylor Pepper, is leading a campaign against the NHS's refusal to approve the drug vorasidenib for brain cancer treatment, arguing it could significantly improve her quality of life.

A national petition and a pending UK Parliament petition are highlighting the human impact of such decisions, emphasizing the importance of quality of life and family time over purely financial considerations.

Vorasidenib is a groundbreaking drug that can delay invasive treatments such as chemotherapy and radiotherapy for patients with IDH-mutant low-grade glioma, and it has successfully helped Taylor shrink her tumor.

The NHS's decision has been described as a 'crushing blow' to brain tumour patients, prompting a campaign supported by local councillor Jade Seager, including a petition urging NICE and the Department of Health to reconsider and negotiate a fair price for the drug.